Pharmaceutical Executive, December 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Articles in this issue
For Investors, ’Tis the Season to be Grateful
Assessing the Unexpected: The Unintended Consequences of COVID on Therapeutics
A ‘Sign’ of the Times: Digital Contract Transformation
Opening Digital Doors: Remote Selling During COVID-19
The C-Suite’s Frontline Workers in Digital Change
Guiding Advice for Leaders Through COVID and Beyond
EU Under Pressure to Make Decisions on Data Sharing
COVID and AMR: Crisis Reframes Antibiotics Fight
Here’s to Looking Ahead
Philanthropy vs. Innovation - Current Vaccine Prices: Is There a Downside?
2020: A Year of Crises, Challenges for FDA & Industry
Biopharma Joins Race to Net-Zero Carbon Emissions
Pharmaceutical Executive, December 2020 Issue (PDF)
Diversity of Thought in Action
The Emergence of Genomics 2.0: Advancing with Data
Recent Videos
Related Content
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Podcast
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
